Fate therapeutics inc. stock
WebApr 5, 2024 · Fate Therapeutics Inc. (NASDAQ:FATE)’s beta value is holding at 1.49, while the average true range (ATR) indicator is currently reading 0.38. Considering analysts … WebApr 11, 2024 · Fate Therapeutics Inc. (FATE) is priced at $5.48 after the most recent trading session. At the very opening of the session, the stock price was $5.81 and reached a high price of $5.81, prior to closing the session it reached the value of $5.85. The stock touched a low price of $5.45.Recently in News on March 3, 2024, Fate Therapeutics to ...
Fate therapeutics inc. stock
Did you know?
WebMar 22, 2024 · Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of programmed cellular immunotherapies for patients with cancer. It uses human induced pluripotent stem cells (iPSCs) generated from its proprietary iPSC product platform to create genetically engineered, clonal master … WebApr 6, 2024 · Let’s start up with the current stock price of Fate Therapeutics Inc. (FATE), which is $5.69 to be very precise. The Stock rose vividly during the last session to $5.65 after opening rate of $5.50 while the lowest price it went was recorded $5.45 before closing at $5.50.Recently in News on March 3, 2024, Fate Therapeutics to Present at …
WebApr 10, 2024 · Fate Therapeutics, Inc. (FATE) NASDAQ: FATE · IEX Real-Time Price · USD. Add to Watchlist 5.59-0.26 (-4.44%) Apr 10, 2024, 2:37 PM EDT - Market open ... Profile; Chart; Stock Price Forecast. According to 30 stock analysts, the average 12-month stock price forecast for FATE stock is $8.48, which predicts an increase of 51.70%. The … WebMainStay VP Small Cap Growth Portfolio Buys Option Care Health Inc, Leslies Inc, Kratos Defense ... GuruFocus.com. Dec-22-21 12:15AM. Fate Therapeutics Inc (FATE) CFO …
WebMar 10, 2024 · Fate Therapeutics Inc Stock Price History. Fate Therapeutics Inc’s price is currently down 20.26% so far this month. During the month of March, Fate Therapeutics Inc’s stock price has reached a high of $6.99 and a low of $4.78. Over the last year, Fate Therapeutics Inc has hit prices as high as $43.12 and as low as $4.02. Year to date, … WebApr 13, 2024 · Fate Therapeutics, Inc. (NASDAQ:FATE - Get Rating) has been assigned a consensus rating of "Hold" from the twenty-three analysts that are currently covering the firm, Marketbeat reports.Two research analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and five have issued a buy …
WebApr 6, 2024 · Fate Therapeutics Inc Stock Price History. Fate Therapeutics Inc’s price is currently up 2.63% so far this month. During the month of April, Fate Therapeutics Inc’s …
WebApr 13, 2024 · Fate Therapeutics Inc. (NASDAQ:FATE) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -0.53% to the previous day’s close … djia avataWebApr 10, 2024 · To see how Fate Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: FATE stock’s performance was 6.36% in the latest trading, and -85.40% in the past year, while Ionis Pharmaceuticals Inc. (IONS) has traded 1.86% on the day and positioned -2.61% lower than it was a year … dji0011WebJun 9, 2024 · Fate Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 927,234 shares of its common stock. The proceeds to Fate Therapeutics from this offering are expected to be approximately $164.2 million after deducting underwriting discounts and commissions and other estimated offering … djia graph todayWebThe Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. djia jan 1 2021WebApr 10, 2024 · Fate Therapeutics Inc Stock Price History. Fate Therapeutics Inc’s price is currently down 3.86% so far this month. During the month of April, Fate Therapeutics … c雙重指標陣列WebJan 6, 2024 · The typical analyst rating for Fate Therapeutics Inc. is Buy. Fate Therapeutics Inc.’s stock analysis by Stock Target Advisor is Slightly Bearish and is … c集合去重WebApr 14, 2024 · Fate Therapeutics Price Performance. Shares of FATE stock opened at $6.20 on Wednesday. The firm has a market cap of $608.60 million, a P/E ratio of -2.13 … djia auslandsjahr